Literature DB >> 8133731

Target heart rates for the development of cardiorespiratory fitness.

D P Swain1, K S Abernathy, C S Smith, S J Lee, S A Bunn.   

Abstract

The American College of Sports Medicine (ACSM) recommends the use of 40%, 60%, 80%, and 85% of maximal oxygen consumption (VO2max) as target values in developing exercise prescriptions. Further, the ACSM states that 55%, 70%, 85%, and 90% of maximal heart rate (HRmax) may be used as indices of these respective levels of % VO2max for the general population. The current study evaluated this relationship between %HRmax and %VO2max in apparently healthy, young adults. Eighty-one men and 81 women between the ages of 18 and 34 engaged in an incremental exercise test to exhaustion. Linear regressions of %HRmax and %VO2max were performed on each subject. From these regressions, target values of %HRmax were computed for each individual. Mean percentages of HRmax were 63%, 76%, 89%, and 92% at 40%, 60%, 80%, and 85% of VO2max, respectively. At all of these values of %VO2max, the values obtained for %HRmax were significantly greater (P < 0.001) than those used by the ACSM. Fitness affected these results, particularly among men. High fit men averaged 2% higher in %HRmax than low fit men at any given value of %VO2max.

Entities:  

Mesh:

Year:  1994        PMID: 8133731

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  33 in total

1.  Do the speeds defined by the American College of Sports Medicine metabolic equation for running produce target energy expenditures during isocaloric exercise bouts?

Authors:  Felipe A Cunha; Robert P G Catalão; Adrian W Midgley; Jonas Gurgel; Flávia Porto; Paulo T V Farinatti
Journal:  Eur J Appl Physiol       Date:  2011-12-15       Impact factor: 3.078

2.  'Resting toucher': a time and motion analysis of elite lawn bowls.

Authors:  Aaron J Silk; John Hammond; Robert P Weatherby
Journal:  J Sports Sci Med       Date:  2006-12-15       Impact factor: 2.988

3.  The use of heart rate to monitor the intensity of endurance training.

Authors:  M B Gilman
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

Review 4.  A Physiologically Based Approach to Prescribing Exercise Following a Sport-Related Concussion.

Authors:  Phillip R Worts; Scott O Burkhart; Jeong-Su Kim
Journal:  Sports Med       Date:  2019-05       Impact factor: 11.136

5.  High-intensity aerobic interval training improves aerobic fitness and HbA1c among persons diagnosed with type 2 diabetes.

Authors:  Eva Maria Støa; Sondre Meling; Lill-Katrin Nyhus; Karl Magnus Mangerud; Jan Helgerud; Solfrid Bratland-Sanda; Øyvind Støren
Journal:  Eur J Appl Physiol       Date:  2017-02-03       Impact factor: 3.078

Review 6.  Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis.

Authors:  D Umpierre; P A B Ribeiro; B D Schaan; J P Ribeiro
Journal:  Diabetologia       Date:  2012-11-16       Impact factor: 10.122

7.  Maintained cerebrovascular function during post-exercise hypotension.

Authors:  Christopher K Willie; Philip N Ainslie; Chloe E Taylor; Neil D Eves; Yu-Chieh Tzeng
Journal:  Eur J Appl Physiol       Date:  2013-01-12       Impact factor: 3.078

Review 8.  The latest on the effect of prior exercise on postprandial lipaemia.

Authors:  Maria I Maraki; Labros S Sidossis
Journal:  Sports Med       Date:  2013-06       Impact factor: 11.136

9.  The effects of performing isometric training at two exercise intensities in healthy young males.

Authors:  Jonathan Derek Wiles; Damian A Coleman; Ian L Swaine
Journal:  Eur J Appl Physiol       Date:  2009-03-11       Impact factor: 3.078

10.  A comparison of physiological responses and rating of perceived exertion in two modes of aerobic exercise in men and women over 50 years of age.

Authors:  S Grant; K Corbett; K Todd; C Davies; T Aitchison; N Mutrie; J Byrne; E Henderson; H J Dargie
Journal:  Br J Sports Med       Date:  2002-08       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.